3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide

C118H113Br2F19N34O10 — CID 160711046

IUPAC3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide
SMILESCc1cc(C(=O)NCc2ncc(F)c(N3CCOCC3)n2)ncc1Nc1cccc(C(F)(F)F)c1.Cc1cc(Nc2cccc(C(F)(F)F)c2)cnc1C(=O)NCc1ncc(F)c(N2CCOCC2)n1.Cc1cn(-c2cc(Nc3ccc(C(=O)NNc4nc(C)cc(NCCN5CCOCC5)n4)nc3)cc(C(F)(F)F)c2)cn1.O=C(NCc1ncc(F)c(N2CCOCC2)n1)c1cc(Br)c(Nc2cccc(C(F)(F)F)c2)cn1.O=C(NCc1ncc(F)c(N2CCOCC2)n1)c1ncc(Nc2cccc(C(F)(F)F)c2)cc1Br
InChIInChI=1S/C28H31F3N10O2.2C23H22F4N6O2.2C22H19BrF4N6O2/c1-18-11-25(32-5-6-40-7-9-43-10-8-40)37-27(35-18)39-38-26(42)24-4-3-21(15-33-24)36-22-12-20(28(29,30)31)13-23(14-22)41-16-19(2)34-17-41;1-14-9-18(28-12-19(14)31-16-4-2-3-15(10-16)23(25,26)27)22(34)30-13-20-29-11-17(24)21(32-20)33-5-7-35-8-6-33;1-14-9-17(31-16-4-2-3-15(10-16)23(25,26)27)11-29-20(14)22(34)30-13-19-28-12-18(24)21(32-19)33-5-7-35-8-6-33;23-15-9-17(28-11-18(15)31-14-3-1-2-13(8-14)22(25,26)27)21(34)30-12-19-29-10-16(24)20(32-19)33-4-6-35-7-5-33;23-16-9-15(31-14-3-1-2-13(8-14)22(25,26)27)10-29-19(16)21(34)30-12-18-28-11-17(24)20(32-18)33-4-6-35-7-5-33/h3-4,11-17,36H,5-10H2,1-2H3,(H,38,42)(H2,32,35,37,39);2*2-4,9-12,31H,5-8,13H2,1H3,(H,30,34);2*1-3,8-11,31H,4-7,12H2,(H,30,34)
InChIKeyRRWBHPYPZVKKAG-UHFFFAOYSA-N
MW2688.20 g/mol
LogP20.24
Rot. Bonds34

About 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide

3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide (PubChem CID 160711046) has the molecular formula C118H113Br2F19N34O10 and a molecular weight of 2688.20 g/mol. Its IUPAC name is 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide.

Molecular Properties

Compound Name3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide
PubChem CID160711046
Molecular FormulaC118H113Br2F19N34O10
Molecular Weight2688.20 g/mol
Exact Mass2684.74
IUPAC Name3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide
SMILESCc1cc(C(=O)NCc2ncc(F)c(N3CCOCC3)n2)ncc1Nc1cccc(C(F)(F)F)c1.Cc1cc(Nc2cccc(C(F)(F)F)c2)cnc1C(=O)NCc1ncc(F)c(N2CCOCC2)n1.Cc1cn(-c2cc(Nc3ccc(C(=O)NNc4nc(C)cc(NCCN5CCOCC5)n4)nc3)cc(C(F)(F)F)c2)cn1.O=C(NCc1ncc(F)c(N2CCOCC2)n1)c1cc(Br)c(Nc2cccc(C(F)(F)F)c2)cn1.O=C(NCc1ncc(F)c(N2CCOCC2)n1)c1ncc(Nc2cccc(C(F)(F)F)c2)cc1Br
InChIInChI=1S/C28H31F3N10O2.2C23H22F4N6O2.2C22H19BrF4N6O2/c1-18-11-25(32-5-6-40-7-9-43-10-8-40)37-27(35-18)39-38-26(42)24-4-3-21(15-33-24)36-22-12-20(28(29,30)31)13-23(14-22)41-16-19(2)34-17-41;1-14-9-18(28-12-19(14)31-16-4-2-3-15(10-16)23(25,26)27)22(34)30-13-20-29-11-17(24)21(32-20)33-5-7-35-8-6-33;1-14-9-17(31-16-4-2-3-15(10-16)23(25,26)27)11-29-20(14)22(34)30-13-19-28-12-18(24)21(32-19)33-5-7-35-8-6-33;23-15-9-17(28-11-18(15)31-14-3-1-2-13(8-14)22(25,26)27)21(34)30-12-19-29-10-16(24)20(32-19)33-4-6-35-7-5-33;23-16-9-15(31-14-3-1-2-13(8-14)22(25,26)27)10-29-19(16)21(34)30-12-18-28-11-17(24)20(32-18)33-4-6-35-7-5-33/h3-4,11-17,36H,5-10H2,1-2H3,(H,38,42)(H2,32,35,37,39);2*2-4,9-12,31H,5-8,13H2,1H3,(H,30,34);2*1-3,8-11,31H,4-7,12H2,(H,30,34)
InChIKeyRRWBHPYPZVKKAG-UHFFFAOYSA-N
XLogP20.24
TPSA503.23 Ų
H-Bond Donors12
H-Bond Acceptors39
Rotatable Bonds34
Heavy Atoms183
Complexity

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002688.20
LogP ≤ 520.24
H-Bond Donors ≤ 512
H-Bond Acceptors ≤ 1039

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide?
The IUPAC name of 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide (CID 160711046) is 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide.
What is the SMILES notation for 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide?
The canonical SMILES for 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide is Cc1cc(C(=O)NCc2ncc(F)c(N3CCOCC3)n2)ncc1Nc1cccc(C(F)(F)F)c1.Cc1cc(Nc2cccc(C(F)(F)F)c2)cnc1C(=O)NCc1ncc(F)c(N2CCOCC2)n1.Cc1cn(-c2cc(Nc3ccc(C(=O)NNc4nc(C)cc(NCCN5CCOCC5)n4)nc3)cc(C(F)(F)F)c2)cn1.O=C(NCc1ncc(F)c(N2CCOCC2)n1)c1cc(Br)c(Nc2cccc(C(F)(F)F)c2)cn1.O=C(NCc1ncc(F)c(N2CCOCC2)n1)c1ncc(Nc2cccc(C(F)(F)F)c2)cc1Br.
What is the InChIKey of 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide?
The InChIKey is RRWBHPYPZVKKAG-UHFFFAOYSA-N. The full InChI is InChI=1S/C28H31F3N10O2.2C23H22F4N6O2.2C22H19BrF4N6O2/c1-18-11-25(32-5-6-40-7-9-43-10-8-40)37-27(35-18)39-38-26(42)24-4-3-21(15-33-24)36-22-12-20(28(29,30)31)13-23(14-22)41-16-19(2)34-17-41;1-14-9-18(28-12-19(14)31-16-4-2-3-15(10-16)23(25,26)27)22(34)30-13-20-29-11-17(24)21(32-20)33-5-7-35-8-6-33;1-14-9-17(31-16-4-2-3-15(10-16)23(25,26)27)11-29-20(14)22(34)30-13-19-28-12-18(24)21(32-19)33-5-7-35-8-6-33;23-15-9-17(28-11-18(15)31-14-3-1-2-13(8-14)22(25,26)27)21(34)30-12-19-29-10-16(24)20(32-19)33-4-6-35-7-5-33;23-16-9-15(31-14-3-1-2-13(8-14)22(25,26)27)10-29-19(16)21(34)30-12-18-28-11-17(24)20(32-18)33-4-6-35-7-5-33/h3-4,11-17,36H,5-10H2,1-2H3,(H,38,42)(H2,32,35,37,39);2*2-4,9-12,31H,5-8,13H2,1H3,(H,30,34);2*1-3,8-11,31H,4-7,12H2,(H,30,34).
What are the key properties of 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide?
3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide has a molecular weight of 2688.20 g/mol, XLogP of 20.24, 34 rotatable bonds, 12 hydrogen bond donors, and 39 hydrogen bond acceptors.
Where does this data come from?
All data for 3-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;4-bromo-N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-3-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;N-[(5-fluoro-4-morpholin-4-ylpyrimidin-2-yl)methyl]-4-methyl-5-[3-(trifluoromethyl)anilino]pyridine-2-carboxamide;5-[3-(4-methylimidazol-1-yl)-5-(trifluoromethyl)anilino]-N'-[4-methyl-6-(2-morpholin-4-ylethylamino)pyrimidin-2-yl]pyridine-2-carbohydrazide is sourced from PubChem (CID 160711046), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).